BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20939807)

  • 1. Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds.
    Cabrini G; Bezzerri V; Mancini I; Nicolis E; Dechecchi MC; Tamanini A; Lampronti I; Piccagli L; Bianchi N; Borgatti M; Gambari R
    Curr Med Chem; 2010; 17(35):4392-404. PubMed ID: 20939807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa.
    Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G
    Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.
    Bezzerri V; Borgatti M; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Rizzotti P; Gambari R; Cabrini G
    Am J Respir Cell Mol Biol; 2008 Jul; 39(1):86-96. PubMed ID: 18258920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.
    Finotti A; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi M; Mancini I; Cabrini G; Saviano M; Avitabile C; Romanelli A; Gambari R
    Artif DNA PNA XNA; 2012; 3(2):97-296. PubMed ID: 22772035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of cystic fibrosis epithelial cells via NF-κB decoy oligonucleotide-coated polysaccharide nanoparticles.
    Wardwell PR; Bader RA
    J Biomed Mater Res A; 2015 May; 103(5):1622-31. PubMed ID: 25087735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
    Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.
    Gambari R; Borgatti M; Lampronti I; Fabbri E; Brognara E; Bianchi N; Piccagli L; Yuen MC; Kan CW; Hau DK; Fong WF; Wong WY; Wong RS; Chui CH
    Int Immunopharmacol; 2012 Jul; 13(3):308-15. PubMed ID: 22561123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells.
    De Stefano D; Ungaro F; Giovino C; Polimeno A; Quaglia F; Carnuccio R
    J Gene Med; 2011 Apr; 13(4):200-8. PubMed ID: 21322102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.
    Borgatti M; Chilin A; Piccagli L; Lampronti I; Bianchi N; Mancini I; Marzaro G; dall'Acqua F; Guiotto A; Gambari R
    Eur J Med Chem; 2011 Oct; 46(10):4870-7. PubMed ID: 21864947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.
    Malcomson B; Wilson H; Veglia E; Thillaiyampalam G; Barsden R; Donegan S; El Banna A; Elborn JS; Ennis M; Kelly C; Zhang SD; Schock BC
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3725-34. PubMed ID: 27286825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells.
    Rebeyrol C; Saint-Criq V; Guillot L; Riffault L; Corvol H; Chadelat K; Ray DW; Clement A; Tabary O; Le Rouzic P
    Cell Signal; 2012 May; 24(5):1093-9. PubMed ID: 22285804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily.
    Borgatti M; Bezzerri V; Mancini I; Nicolis E; Dechecchi MC; Lampronti I; Rizzotti P; Cabrini G; Gambari R
    Biochem Biophys Res Commun; 2007 Jun; 357(4):977-83. PubMed ID: 17466942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.
    Tupini C; Chilin A; Rossi A; De Fino I; Bragonzi A; D'Aversa E; Cosenza LC; Vaccarin C; Sacchetti G; Borgatti M; Tamanini A; Dechecchi MC; Sanvito F; Gambari R; Cabrini G; Lampronti I
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway.
    Escotte S; Tabary O; Dusser D; Majer-Teboul C; Puchelle E; Jacquot J
    Eur Respir J; 2003 Apr; 21(4):574-81. PubMed ID: 12762338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells.
    Cigana C; Nicolis E; Pasetto M; Assael BM; Melotti P
    Biochem Biophys Res Commun; 2006 Dec; 350(4):977-82. PubMed ID: 17045242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of interleukin-8 production by inhibiting nuclear factor-kappaB translocation using decoy oligonucleotides.
    Cooper JA; Parks JM; Carcelen R; Kahlon SS; Sheffield M; Culbreth R
    Biochem Pharmacol; 2000 Mar; 59(6):605-13. PubMed ID: 10677576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the I(k)B kinase alpha/beta complex.
    Tabary O; Muselet C; Escotte S; Antonicelli F; Hubert D; Dusser D; Jacquot J
    Am J Pathol; 2003 Jan; 162(1):293-302. PubMed ID: 12507912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.